Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LXT-101

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
OBJECTIVES To demonstrate the correlation between the nanostructure formation and the long duration of action in vivo of peptides… Expand
  • figure 1
  • figure 2
Is this relevant?
2013
2013
LXT-101, a cationic peptide is a novel antagonist of gonadotropin-releasing hormone (GnRH) for prostate cancer treatment. However… Expand
  • figure 2
  • figure 4
  • figure 6
Is this relevant?
2011
2011
OBJECTIVES Multivesicular liposomes (MVLs) are often used as an appropriate carrier for delivering peptides due to high drug… Expand
Is this relevant?
2011
2011
The introduction of luteinizing hormone-releasing hormone (LHRH) analogs and their antagonists is revolutionizing the treatment… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2009
2009
Using a simple method to determine the interaction between peptide and lipid bilayer and then deciding how to modify formulation… Expand
Is this relevant?
2008
2008
This paper developed a sensitive and specific liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/MS) method… Expand
Is this relevant?
2006
2006
A sustained release poly(DL-lactide-co-glycolide) (PLGA) microsphere delivery system to treat prostate cancer for a luteinizing… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2006
2006
LXT-101 is a newly developed GnRH (gonadotropin-releasing hormone) analogue. In this study, the in vivo pharmacological profile… Expand
Is this relevant?
2005
2005
AIM The biological characterization of LXT-101 was investigated in vivo using intact male rats and nude mice bearing xenografts… Expand
Is this relevant?
2004
2004
AIM: To investigate the pharmacological effect of LXT-101 on serum testosterone level in intact male rats. METHODS: Ratswere… Expand
Is this relevant?